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INTRODUCTION
Sleep complaints constitute one of the most common diffi-
culties facing middle-aged and older adults.1 Indeed, epidemi-
ological studies suggest that most community-dwelling older 
adults have some concerns about their ability to fall asleep or 
stay asleep, with fewer than 20% reporting “rarely” or “never” 
having any sleep complaints.2 Older adults often take longer to 
fall asleep, wake more frequently during the night, and experi-
ence lower sleep efficiency than their younger counterparts.3 
Importantly, these objective age-related changes in sleep 
across the life span are often associated with self-reports of 
poor sleep quality.4-6
One pathway through which both objective and subjective 
measures of sleep may be associated with health is inflamma-
tion. Sleep is closely linked to immune system changes via the 
sleep-wake cycle, with immune cells at their highest blood levels 
in the early evening and lowest in the morning,7 and disruption 
of the regular sleep-wake cycle appears to significantly affect 
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immune function.8,9 Importantly, sleep deprivation has been 
found to induce increases in circulating levels of inflammatory 
markers, such as tumor necrosis factor-α (TNF-α),10 C-reactive 
protein (CRP),11 and interleukin-6 (IL-6),12 with significant 
elevations occurring after only 1 night of sleep loss.11 Addi-
tionally, experimentally induced sleep deprivation in the labo-
ratory has also been associated with nuclear factor kappa- B 
cell (NF-κB) activation, a molecular pathway through which 
sleep disturbance may influence leukocyte inflammatory gene 
expression and inflammation-related disease risk.13 This body 
of literature demonstrates effects of sleep loss on a range of 
well-known markers of the acute inflammatory system, inde-
pendent of actual injury or infection to the host. The combina-
tion of high prevalence of sleep problems among older adults, 
as well as the effects of sleep loss on inflammatory processes, 
may put older adults at increased risk for many chronic condi-
tions, because aging alone is associated with low-grade eleva-
tion of inflammatory markers.14
In addition to increased inflammation during chronological 
aging, inflammation also appears to play a role in cellular 
aging. Immune system cells are under tremendous prolifera-
tive demand, requiring telomeres to remain intact. Telomeres 
are repetitive structures at the end of chromosomes that help 
to promote cellular stability.15,16 However, with each succes-
sive replication of the cell, telomeres shorten and when a crit-
ical threshold is met, the result is cellular senescence. In all 
mitotic tissues aside from germline tissue, telomere length (TL) 
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declines with age.17,18 Telomere activity serves several critical 
genomic purposes, including the prevention of chromosomal 
fusions and unregulated cellular activity.19 Lymphocytes, an 
immune cell, are capable of upregulating the enzyme (telom-
erase) that elongates telomeres, prolonging cellular life span.20 
In addition, recent work demonstrates telomere shortening in 
monocytes is associated with increased synthesis of proinflam-
matory cytokines.21 Although the set point of TL appears to be 
genetically determined,22 it is not yet fully understood what 
drives age-associated telomere loss, although several factors 
have been identified (e.g., chronic stress and proliferation-
induced shortening). 20
A small but growing body of literature now demonstrates 
associations between sleep and TL.23-27 Of these studies, three 
provide evidence that self-reported sleep quality and sleep 
duration are related to TL. For example, Prather and colleagues 
found an association between self-reported sleep quality among 
middle-aged women and TL, such that women who reported 
poorer sleep quality had shorter leukocyte TL.26 This finding 
has recently been replicated in healthy men (Mage = 63.3, 
standard deviation = 5.6).27 In addition, Liang and colleagues 
found that long sleep duration was significantly associated 
with long TL among women younger than 50 years, but not 
among women older than 50 years.25 These findings raise the 
question of whether associations between sleep quality, sleep 
duration, and TL change as we age. That is, as we get older, 
do sleep duration and self-reported sleep quality differentially 
predict TL compared to a relatively younger population? These 
prior studies suggest that further study examining associations 
between sleep duration, self-reported sleep quality, and TL is 
warranted.
The purpose of the current study was to examine associa-
tions among age, subjective sleep quality, sleep duration, and 
telomere length in a sample of middle-aged and older adults. 
The first aim was to replicate prior findings of an association 
between age and TL. A second aim was to replicate recent 
findings demonstrating associations between subjective sleep 
quality and self-reported sleep duration with TL, with the 
prediction that poorer sleep quality and shorter sleep dura-
tion would be associated with shorter TL.26 Additionally, prior 
research suggests a U-shaped association between sleep dura-
tion and negative health effects.28 A third aim of the current 
study was to examine a nonlinear model. Chronological age 
is generally associated with poorer sleep quality as well as 
cellular aging, and poor sleep quality is linked to shorter TL. 
Thus, it was predicted that increasing age would be associated 
with shorter TL among those reporting shorter sleep duration 
and poorer sleep quality.
METHOD
Participants
As part of a larger study, 154 relatively healthy participants 
(89 men and 65 women) were included in this study. An addi-
tional 23 participants were studied, but for various reasons had 
no telomere data (e.g., blood draw or blood separation prob-
lems). Importantly, comparing these individuals with partici-
pants who had complete data on age—the only demographic 
factor related to telomere length—revealed no significant 
group differences (mean age = 60.1 versus 60.6, P > 0.70). 
We recruited a middle-aged to older adult sample (45 to 77 y 
[Mage = 60.1, standard deviation = 6.76]) to allow for greater 
variability in TL. Because many older adults are on some 
form of medication, we only excluded individuals who were 
on immunosuppressive treatment (e.g., corticosteroid therapy) 
and/or had current cancer or human immunodeficiency virus 
to address concerns about potential effects on peripheral blood 
mononuclear cells (PBMCs), which we used for the determina-
tion of TL. Corticosteroid therapy and treatment regimen are 
factors known to influence immune cell function.29 Because 
there was little evidence on the extent of such influences on TL 
determined from these cells at the time of the study, we conser-
vatively used them as exclusion criteria.
Procedure
The current investigation was performed in accordance 
with the ethical standards of the University of Utah institu-
tional review board. All eligible participants were scheduled 
for an appointment at the Social Neuroscience Laboratory, 
and following informed consent, were rechecked against the 
exclusion criteria. Participants then completed a demographic 
questionnaire (e.g., age, sex) and the Pittsburgh Sleep Quality 
Index (PSQI).30 Following completion of the questionnaires, 
approximately 20 cc of blood were drawn and treated with 
EDTA to prevent clotting. Telomere length was determined 
using PBMCs. DNA from the PBMCs was extracted from fresh 
cells, which were separated using density gradient centrifuga-
tion with Ficoll-Hypaque (GE Healthcare). Following the blood 
draw, participants were debriefed and received $75.00 for their 
participation.
Measures
Pittsburgh Sleep Quality Index
The PSQI30 assesses sleep habits during the previous month. 
The scale is composed of 19 items, which are used to derive 
seven component scores: sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep disturbances, sleep 
medication, and daytime dysfunction. Component scores on 
the PSQI are summed to produce a global measure of subjec-
tive sleep quality score, with higher scores indicating poorer 
sleep quality. This instrument has demonstrated good reliability 
(alpha = 0.83) and validity.31 For the current study, the sleep 
duration component score and the item assessing sleep quality 
were used.
Telomere Length
DNA was extracted from isolated PBMCs using the reagents 
and protocols contained in Qiagen’s Gentra Puregene Blood 
Kit, Catalog # 158389, with the exception that the red blood 
cell lysis step was skipped, as it was unnecessary due to prior 
removal of RBCs by centrifugation. Relative TLs were then 
determined for the PBMCs using quantitative polymerase chain 
reaction (PCR). For each DNA sample, we measured the factor 
by which the sample differed from a reference DNA sample in 
its ratio of telomere repeat copy number to single copy gene 
copy number. This ratio is proportional to the average TL (T/S 
ratio).32 These assays were run in several batches, and each 
SLEEP, Vol. 37, No. 1, 2014 67 Cellular Aging and Restorative Processes—Cribbet et al
batch consisted of DNA samples from 96 participants per quan-
titative PCR run. The interassay geometric mean of the coeffi-
cient of variation for this assay was 3.13%, based on examining 
the variation in the mean T/S ratio across days.33 The intra-assay 
geometric mean of the coefficient of variation was 5.22%. This 
was determined by examining variations in the T/S of samples 
across triplicate repeat measurements of the samples, collected 
in the same run.33 Outliers were determined within triplicate 
measurements of T/S for a given sample: when PCR ampli-
fication of either the telomere target and/or the single copy 
gene target failed for one of the three replicates, that replicate 
was removed from the analysis. When amplification of two or 
more of the three replicates of a sample failed, the assay was 
repeated in triplicate for that DNA sample. The Shapiro-Wilk 
test of normality, which is appropriate for this sample size, 
was 0.98, indicating a high degree of normality in the resulting 
T/S ratio data.
Overview of Analyses 
To characterize the sample with respect to age, sleep dura-
tion, self-reported sleep quality, and telomere length, means, 
standard deviations and zero-order correlations among these 
variables were calculated.
Separate regression analyses examined independent asso-
ciations among age, sleep duration (PSQI component score), 
subjective sleep quality (PSQI item), and TL. All models 
included covariates known to be associated with telomere length 
(sex; body mass index; average weekly alcohol consumption; 
average weekly tobacco use; average weekly exercise; use of 
hormone replacement therapy; and use of hypertension, choles-
terol, and diabetes medications). All variables were centered to 
minimize multicollinearity.34
To examine the moderating effects of sleep duration and 
self-reported sleep quality on the association between age and 
TL, separate regression models that included first-order effects 
and the cross product terms (e.g., age × sleep quality) were 
conducted, adjusting for the covariates just listed. In order to 
probe significant interactions, separate regression models were 
restructured on high and low values (one standard deviation 
above and below the mean) of sleep duration and sleep quality, 
respectively.34
Finally, because prior research suggests a U-shaped asso-
ciation between sleep duration and negative health effects,28 
a nonlinear model was also examined. Significant interac-
tions were probed by restructuring the regression model one 




Means, standard deviations, and correlations among the 
study variables are presented in Table 1. Age was significantly 
inversely correlated with the sleep duration component of the 
PSQI and the PSQI item about self-reported sleep quality. The 
well-known association between age and TL was replicated 
(b = -0.011, t = -3.83, P = 0.0002).
Because prior research on sleep in older adults suggests that 
sleep duration and sleep quality are important for health,3-6 we 
examined the PSQI sleep duration component and self-reported 
sleep quality item. In all regression models, variables were 
centered to minimize multicollinearity. In separate regression 
models that included the PSQI sleep duration component and 
the PSQI sleep quality item scores age remained a significant 
predictor of TL (P < 0.001), above and beyond the following 
covariates: sex, body mass index, average weekly alcohol 
consumption, average weekly tobacco use, average weekly 
exercise, use of hormone replacement therapy, use of hyperten-
sion, cholesterol, diabetes medications.
To examine the moderating effect of sleep duration and sleep 
quality on the association between age and TL, separate regres-
sion models that included centered first-order effects and the 
cross product terms (age × sleep quality item; age × sleep dura-
tion component score) were conducted. One significant inter-
action emerged. There was a significant interaction between 
age and self-reported sleep quality (b = -0.011, t = -2.42, 
P < 0.05, ΔR2 = 0.04) above and beyond sex, body mass index, 
average weekly alcohol consumption, average weekly tobacco 
use, average weekly exercise, use of hormone replacement 
therapy, and use of medications for hypertension, cholesterol, 
and diabetes. No other main effects or interactions of these 
PSQI scores emerged. In order to probe the significant age × 
self-reported sleep quality interaction, the regression model 
was restructured on high and low values (one standard devia-
tion above and below the mean) of self-reported sleep quality 
(item).34 As displayed in Figure 1 (which displays plotted values 
one standard deviation above and below the mean of the PSQI 
item about self-reported sleep quality), follow-up analyses 
Table 1—Means, standard deviations, and zero-order correlations 
among study variables
Variable 1 2 3 4
1. Telomere length – -0.29b 0.04 0.08
2. Age  – -0.26b -0.17a
3. Self-reported sleep quality   – 0.40b
4. Sleep duration    –
Mean 0.97 60.13 0.88 0.62
Standard deviation 0.25 6.57 0.69 0.86
Telomere length represented as T/S ratio. aP < 0.05. bP < 0.001.
Figure 1—Subjective sleep quality attenuates the effect of age on 
telomere length.
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revealed that age was more strongly negatively related to TL 
among those with poor self-reported sleep quality (b = -0.021, 
P ≤ 0.0001) than those with better self-reported sleep quality 
(b = -0.005, P = 0.24), suggesting that sleep quality attenuated 
the effect of age on TL.
Finally, given prior research suggesting that both high and 
low sleep duration may have negative health effects (i.e., 
a curvilinear effect),28 a nonlinear association between the 
component score of sleep duration and TL was examined in a 
regression model that included sex, age, the linear sleep dura-
tion term (component score), and a quadratic sleep duration 
term. There was a significant association between the quadratic 
sleep duration term and telomere length (b = 0.05, P < 0.05) 
above and beyond sex; body mass index; average weekly 
alcohol consumption; average weekly tobacco use; average 
weekly exercise; use of hormone replacement therapy; use of 
hypertension, cholesterol, and diabetes medications; and chron-
ological age. Moreover, age moderated the association between 
the quadratic sleep duration term and TL (b = 0.013, t = 3.61, 
P < 0.001, ΔR2 = 0.08). In order to probe the significant interac-
tion, the regression model was restructured one standard devia-
tion above and below the means for both age and the quadratic 
sleep duration term.34 Analysis of simple slopes revealed that 
sleep duration was unrelated to TL for the middle-aged adults 
in our sample (P > 0.10). However, adequate sleep duration 
(i.e., > 6.9 h/night) in older adults was positively associated 
with TL (b = 0.25, P < 0.01). Moreover, it appears that the bene-
fits of adequate sleep duration begin around age 60 y (b = 0.06, 
P < 0.05). Although the simple slope for older adults with low 
sleep duration (< 5 h/night) was also significant (b = 0.12, 
P < 0.01), very few older adults reported sleep duration this low 
(n = 4) and the predicted TL in this group was well below that of 
the middle-aged participants. Figure 2 shows mean TL values 
based on the range of values for the sleep duration component 
on the PSQI and on values one standard deviation above and 
one standard deviation below the mean of age (Mage = 60.57 y). 
TL for older adults with adequate sleep duration (i.e., > 6.9 h/
night) is comparable to that of the middle-aged group. Thus, 
adequate sleep duration in older adults appears to be associated 
with attenuated aging, as indicated by TL.
DISCUSSION
In this study we examined associations between chrono-
logical age, cellular aging, sleep duration, and subjective sleep 
quality in a sample of middle-aged and older men and women. 
Consistent with prior research and our first aim, we found an 
inverse association between age and TL. For our second aim, 
we did not find the PSQI item of self-reported sleep quality to 
significantly predict TL on its own. However, it did moderate 
the association between age and TL, suggesting that among 
older adults, better sleep quality was significantly associated 
with longer TL; this pattern was not found for younger adults in 
this sample. Similar to findings by Jackowska and colleagues, 
results of the current study indicated a nonlinear association 
between the component of sleep duration and TL, such that 
both high and low sleep durations were associated with shorter 
TL.27 This nonlinear effect varied with age such that there was 
evidence of longer TL for older adults with adequate sleep 
duration; however sleep duration was unrelated to TL for the 
middle-aged adults in our sample.
The current study replicates and extends recent findings on 
the links between aging and TL. However, the current study 
differs from prior studies in important ways. First, the current 
study is the first to use both men and women in examining the 
association between PSQI measures of sleep quality and sleep 
duration with TL. Next, in contrast to findings of Liang and 
colleagues, results of the current study showed the sleep dura-
tion component was significantly associated with TL among 
older adults compared to middle-aged adults.25 We interpret 
current results to suggest that getting an adequate amount of 
sleep in older adulthood is potentially buffering deleterious 
effects of TL shortening that normally occur with age; thus, 
sleep is demonstrated to be a restorative process at the cellular 
level in older adults. Future research should examine the 
circumstances that shape how sleep duration influences cellular 
aging. These general findings are consistent with prior work 
showing the importance of subjective sleep quality and dura-
tion as predictors of TL.
TL, a marker of cellular aging, has been related to other 
psychosocial factors known to affect health, such as chronic 
stress,35 divorce,36 and childhood trauma.37 Thus, the results 
of this investigation may have implications for understanding 
the mechanisms through which daily metabolic insults such 
as stress affect health in older adults.38 Within this general 
framework, stress exposure, stress reactivity, stress recovery, 
and restoration are component processes by which stress 
adversely affects health, and sleep is considered to be a restor-
ative process.39,40 Inadequate sleep is associated with adverse 
health consequences including impaired immune functioning,41 
susceptibility to the common cold,42 metabolic syndrome,43,44 
inflammatory processes,45 coronary artery calcification,46 coro-
nary heart disease,47 and type 2 diabetes.48 Moreover, among 
middle-aged and older adults, sleeping less than 7 h or more 
than 8 h is associated with poor health outcomes28 and increased 
mortality rates.49 The data from this study highlight the poten-
tial positive effect of better sleep quality and longer sleep dura-
tion, especially for older adults.
As shown in Table 1, the older adults in this study reported 
better sleep quality (PSQI sleep quality item) and slept longer 
(PSQI sleep duration component) than their middle-aged 
Figure 2—Mean telomere length among middle-aged and older adults 
by hours of sleep per night (Pittsburgh Sleep Quality Index component 
sleep duration).
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counterparts. These findings are inconsistent with the view 
that older adults report more sleep complaints and experience 
a decline in sleep quality over the life span.2-6 However, this 
sample was composed of relatively healthy middle-aged and 
older adults, and results of the current study are consistent with 
prior research indicating that sleep complaints among older 
adults are not the result of age per se, but are often secondary 
to physical health problems.50-52 Moreover, the results of the 
current study are consistent with findings from a recent popu-
lation-based study of subjective sleep quality across the life 
span showing a decline in sleep quality until age 60 y, followed 
by a transient increase in sleep quality from age 60 y to 66 y, 
then a plateau in sleep quality after age 66 y.53 Although the 
finding that the older adults in this study reported better sleep 
quality than their middle-aged counterparts is in contrast to the 
view that sleep quality declines with age, these results suggest 
a growing need for a more differentiated description of changes 
in sleep quality during old age.
There are some limitations to the current study. First, the 
participants were a relatively healthy community sample of 
older adults, so generalizations to chronically ill populations 
and other age groups should be made cautiously. Future research 
should examine the association between TL and self-reported 
sleep quality in the context of diagnosed sleep disorders, such as 
insomnia and obstructive sleep apnea (OSA), especially in light 
of evidence that OSA in adults has been linked to shorter TL,54 
whereas OSA in children has been associated with longer TL.55 
Thus, more work examining connections between OSA and TL 
is needed before attempting to understand the role self-reported 
sleep quality may play in that relationship. Additionally, the 
data are cross-sectional in nature, limiting the ability to draw 
causal inference. Moreover, only 2% to 3% of the total variance 
in TL was explained by interactions between age and the indi-
vidual item of sleep quality, indicating a fairly modest effect. 
Longitudinal investigations may increase our understanding 
of how poor sleep quality affects cellular aging throughout 
adulthood. Although self-reported sleep quality is important to 
examine and figures prominently in the development of chronic 
sleep disturbance, investigating these associations using objec-
tive indices of sleep (e.g., actigraphy and polysomnography) 
will be important. Relating indices of cellular aging to circadian 
and homeostatic processes may also help to clarify the mecha-
nism through which sleep affects cellular aging.
Despite these limitations, the current study provides evidence 
for an association between subjective sleep quality, sleep dura-
tion, and cellular aging processes among middle-aged and older 
adults. These data suggest that sleep and subjective sleep quality 
and sleep duration can be added to a growing list of modifiable 
health behaviors linked to shorter TL.56-61 Thus, interventions 
aimed at improving modifiable aspects of sleep may help to 
lessen the adverse effects associated with cellular aging.
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